Vioxx News
Most Popular Vioxx Story
New drug approval lags in 2007
The FDA has suffered no small amount of criticism recently, and, according to the Wall Street Journal, the agency's efforts to protect itself from naysayers have contributed significantly to he low... Read more...
Latest Headlines
- May 5, 2008
- March 26, 2008
- March 12, 2008
- January 10, 2008
- January 9, 2008
- December 13, 2007
- November 9, 2007
- November 2, 2007
- August 8, 2007
- January 1, 2007
- December 12, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
